Value
8.2/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 8.6 |
| P/S | 8.8 |
| EV/EBITDA | 7.6 |
| Fwd P/E | 9.3 |
| PEG | 10.0 |
| Analyst target | 5.0 |
- ▸Forward P/E: 9.6x
- ▸PEG: 0.38
- ▸Attractively valued
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Ategrity Specialty Insurance is growing quickly (quarterly revenue up about 46% YoY) at a cheap 9.6x forward P/E, but the October 2026 earnings miss, heavy casualty and parent-counterparty concentration, and only 3.7% upside to the analyst target limit the case.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
Quarterly revenue reached about $148.5M in the June 2026 quarter versus $101.8M a year earlier, roughly 46% YoY growth. Revenue quarters | Quarterly revenue should keep growing and stay above $150M within the next 12 months. | Tripped↓Deteriorating |
| CounterGrowth confidence is 0.67 and the next-quarter revenue estimate is reported as 0.0, so forward growth visibility is poor and the pace may slow. | ||
Ategrity beat EPS estimates in 3 of the last 4 quarters with an average surprise of 13.0%, but the October 2026 quarter missed by 41.9% (0.29 vs 0.50). Earnings | EPS should return to meeting or beating estimates at the next report on 2027-02-18. | ↓Deteriorating |
| CounterThe latest miss was large and underwriting results for a young specialty insurer are volatile, so the earlier beat streak may not predict future results. | ||
The stock trades at a forward P/E of 9.6x with a PEG of 0.38, an attractively valued profile with a value score of 8.2/10. Valuation breakdown | Forward P/E should stay below 12x as earnings grow over the next 12 months. | →Stable |
| CounterInsurers often trade at low multiples, and the recent EPS miss suggests forward estimates may be cut, which would raise the true forward multiple. | ||
The business is concentrated, with casualty making up 67.2% of the product mix and Ategrity Limited accounting for 80.0% of the counterparty exposure. Bear case | Casualty share should not rise above 67.2% and the counterparty reliance on Ategrity Limited should not exceed 80%. | →Stable |
| CounterHeavy casualty exposure can bring reserve deficiencies and adverse development, and dependence on a single counterparty means a disruption there would hit results directly. | ||
Price is only 3.7% below the $24.71 analyst target while downside to the stop is 9.6%, a reward-to-risk of 0.39, and momentum is weak at 3.1/10. Estimated upside | Reward-to-risk should improve toward 1.5 on a pullback or a higher analyst target before an entry is attractive. | →Stable |
| CounterRSI of 38 marks an uptrend pullback above the 200-day average and the first insider buy has appeared, so the weakness may be a buying opportunity. | ||
CounterGrowth confidence is 0.67 and the next-quarter revenue estimate is reported as 0.0, so forward growth visibility is poor and the pace may slow.
CounterThe latest miss was large and underwriting results for a young specialty insurer are volatile, so the earlier beat streak may not predict future results.
CounterInsurers often trade at low multiples, and the recent EPS miss suggests forward estimates may be cut, which would raise the true forward multiple.
CounterHeavy casualty exposure can bring reserve deficiencies and adverse development, and dependence on a single counterparty means a disruption there would hit results directly.
CounterRSI of 38 marks an uptrend pullback above the 200-day average and the first insider buy has appeared, so the weakness may be a buying opportunity.
| Component | Sub-score |
|---|---|
| P/E | 8.6 |
| P/S | 8.8 |
| EV/EBITDA | 7.6 |
| Fwd P/E | 9.3 |
| PEG | 10.0 |
| Analyst target | 5.0 |
| Component | Sub-score |
|---|---|
| ROE | 5.4 |
| ROA | 3.4 |
| Gross margin | 1.0 |
| Op margin | 4.7 |
| Net margin | 9.4 |
| Current ratio | 5.4 |
| Moat | 6.2 |
| Piotroski F | 6.7 |
| Component | Sub-score |
|---|---|
| Rev growth | 4.5 |
| EPS growth | 7.0 |
| Component | Sub-score |
|---|---|
| RSI | 5.5 |
| MACD | 0.0 |
| OBV | 10.0 |
| MA position | 4.0 |
| Volume | 1.5 |
| Component | Sub-score |
|---|---|
| Analyst rating | 6.5 |
| Price target | 7.3 |
| erm sentiment | 5.0 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 6.0 |
| Component | Sub-score |
|---|---|
| value rank | 3.7 |
| quality rank | 6.1 |
| growth rank | 5.4 |
| Component | Sub-score |
|---|---|
| bollinger | 7.0 |
| support resistance | 7.5 |
| 52w position | 6.8 |
| Component | Sub-score |
|---|---|
| short interest | 8.1 |
| days to cover | 5.6 |
| volatility | 0.7 |
| debt equity | 10.0 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 9.0 |
Maintain position. Not compelling to add more.
L4:PATH_F_HOLDnone
SetupRange Bound — RSI 42 mid-range, Bollinger mid-band
EdgeInst Constrain — Small cap ($1.1B) below institutional reach
SuitabilitySpeculative — Binary industry: Insurance - Property & Casualty
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: INSIDER:OK. Top dim: Value at 8.2; weakest: Momentum at 4.2. No conviction either direction.
The strongest dimensions are Value at 8.2, Technical at 7.1, and Catalyst at 6.4; the weakest are Momentum at 4.2, Quality at 5.3, and Insider at 5.5. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of 0.18 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifQuarterly revenue growth falls below 20% YoY from current roughly 46%.
Trip ifEPS surprise stays below 0% for 2 consecutive quarters.
Trip ifForward P/E rises above 14x from current 9.6x.
Trip ifAtegrity Limited counterparty share exceeds 90% from current 80%.
Trip ifReward-to-risk exceeds 1.5 from current 0.39.